Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

Neuronet

Leadership blog with Laurent Pradier from SANOFI, Programme Intergration Co-Leader

3rd March 20201st March 2020
Laurent PRADIER Sanofi Work Package 2 Programme Integration leadership blog

What is your current role in the company you work at? I am the lead

Neuronet and Alzheimer Europe team up for European Parliament Lunch Debate on the Innovative Medicines Initiative’s work to advance Alzheimer’s research

3rd August 202219th February 2020
The IMI Advancing Alzheimer’s research through public-private partnerships, Pierre Meulien, Bart Vannieuwenhuyse, Christophe Hansen, Jean Georges, Carlos Diaz

On 18 February, Alzheimer Europe held its first lunch debate of 2020. The debate was

Neuronet holds Consortium meeting in Brussels

27th February 202018th February 2020
Neuronet logo - The support action for EU research on neurodegeneration holds meeting on key assets

On 18 February, the Efficiently Networking European Neurodegeneration Research (Neuronet) Coordination and Support Action held

Neuronet convenes third Scientific Coordination Board meeting in Madrid

24th May 202329th January 2020
Neuronet Scientific Coordination Board Meeting Madrid January 2020, From left to right, Martin Hoffmann-Apitius, Mercè Boada, Jean Georges, Manuela Rinaldi, Andreas Ebneth, Nina Coll, Jochen Prehn, Hugh Marston, Carlos Diaz, Craig Ritchie, Sandra Pla, Christophe Bintener, Lennert Steukers

On 28 January (Madrid, Spain), Neuronet convened its 3rd Scientific Coordination Board meeting. The Board

Second Neuronet newsletter issue launched

19th January 20226th January 2020
Neuronet logo - The support action for EU research on neurodegeneration holds meeting on key assets

Welcome to the second issue of the Neuronet newsletter! This second newsletter issue provides you

Neuronet meeting focuses on key assets and collaborations of IMI neurodegeneration projects

4th February 202020th November 2019
Neuronet logo - The support action for EU research on neurodegeneration holds meeting on key assets

On 20 November (Madrid, Spain), Neuronet held a team meeting on key assets with representatives

Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond

14th January 202225th October 2019
Neuronet annual event parallel session, José Luis Molinuevo AMYPAD; Craig Ritchie, EPAD; Mercè B oada MOPEAD; Dag Aarsland, RADAR-AD

Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together

Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague

14th January 202223rd October 2019
Neuronet Scientific Coordination Board meeting The Hague Alzheimer Europe

On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second

Neuronet consortium meeting held at Johnson & Johnson headquarters in Belgium

4th February 20207th October 2019
Neuronet Consortium meeting at Johnson and Johnson Headquarters in Diegem Belgium, Presentation by Nina Coll from Synapse

On 7 October, Neuronet held its third consortium meeting at Johnson & Johnson headquarters in Diegem, Brussels.

First Neuronet newsletter issue launched

19th January 202219th September 2019
Neuronet logo - The support action for EU research on neurodegeneration holds meeting on key assets

Welcome to the first Neuronet newsletter! Neuronet is a collaborative effort to improve collaboration and

Post navigation
Older posts
Newer posts
← Previous Page1 … Page4 Page5 Page6 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2025 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT